Agenus Reports 51% 18-Month Survival With BOT+BAL in MSS Colorectal Cancer
SIOG 2026: 15 Posts Not to Miss from the Annual Conference in Valencia
Cesaltina Lorenzoni: Cancer Care Challenges in African Conflict Zones at LGCW 2026
ESMO 2026 Reshapes Metastatic Breast Cancer Treatment: ADCs Move Into First Line as Biomarkers Guide New Strategies
SABR Versus Surgery in Early-Stage NSCLC: New JCO Study Supports Surgical Resection, With Important Questions for Older Patients
UNICORN Phase 2: Neoadjuvant Botensilimab Plus Balstilimab Shows Promising Activity in pMMR and dMMR Colon Cancer
Kim Nichols Shares New Guideline on Genetic Testing for Childhood Cancer Survivors
Pharma CEOs Meet in New York: What's at Stake for Cancer Drugs?
